T. Rowe Price Associates’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
|
|||||
2023
Q2 | $2.96M | Sell |
|
|||||
2023
Q1 | $166M | Buy |
|
|||||
2022
Q4 | $104M | Buy |
|
|||||
2022
Q3 | $61.8M | Buy |
|
|||||
2022
Q2 | $32.6M | Sell |
|
|||||
2022
Q1 | $77.6M | Sell |
|
|||||
2021
Q4 | $84.4M | Buy |
|
|||||
2021
Q3 | $80.9M | Buy |
|
|||||
2021
Q2 | $13M | Sell |
|
|||||
2021
Q1 | $13.4M | Buy |
|
|||||
2020
Q4 | $14.9M | Sell |
|
|||||
2020
Q3 | $12.3M | Sell |
|
|||||
2020
Q2 | $14.4M | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $2.8M | Sell |
|
|||||
2016
Q3 | $94.8M | Buy |
|
|||||
2016
Q2 | $90.2M | Sell |
|
|||||
2016
Q1 | $74.7M | Buy |
|
|||||
2015
Q4 | $129M | Sell |
|
|||||
2015
Q3 | $78.5M | Sell |
|
|||||
2015
Q2 | $105M | Buy |
|
|||||
2015
Q1 | $65.2M | Buy |
|
|||||
2014
Q4 | $61.5M | Buy |
|
|||||
2014
Q3 | $53.3M | Buy |
|
|||||
2014
Q2 | $50.5M | Buy |
|
|||||
2014
Q1 | $35.6M | Buy |
|
|||||
2013
Q4 | $26.8M | Buy |
|